Advertisement

Topics

J&J drugs sales outperform despite generic hit

06:23 EDT 16 Apr 2019 | BioPharmaDive

Kicking off first quarter earnings for the industry, J&J managed to post better-than-expected pharma results despite falling Zytiga sales in the U.S.

Original Article: J&J drugs sales outperform despite generic hit

NEXT ARTICLE

More From BioPortfolio on "J&J drugs sales outperform despite generic hit"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...